The new protocol helps health care providers determine which patients need hospital admission and those whose needs can be met with outpatient treatment.
UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.
The effects of this new low-molecular-weight synthetic heparin can be quickly reversed unlike the effects of low-molecular-weight heparin currently in use.
When we fight an infection -- any invader -- our bodies conjure inflammatory responses, immune responses. But inside some individual cells, a similar reaction happens. Beth Knight, PhD, found out what transpires inside such cells involved in a kind of brain cancer called medulloblastoma and what role a particularly important protein plays in cancer development. This is the second profile in a continuing series of features on UNC School of Medicine graduate students.
The research of William Powers, MD, has illuminated our understanding of stroke and guided better treatment for patients throughout three decades, a feat which earned him a Feinberg Award from the American Stroke Association.
Researchers at the UNC Lineberger Comprehensive Cancer Center found that bladder cancer subtypes are genetically similar to breast cancer subtypes.
The Kay Yow Cancer Fund®, in partnership with The V Foundation for Cancer Research, has awarded a $1 million women’s cancer research grant to UNC Lineberger to evaluate the impact of physical activity among breast cancer survivors.
American Stroke Association honors outstanding contributors to stroke research
The university's culture of collaboration is leading to new possibilities for diagnosing and attacking cancers – by using robots.
In this new series, we profile graduate students who conduct research in labs across the UNC School of Medicine. First up is Kizzmekia Corbett, who received an off-campus dissertation fellowship from the UNC Graduate School to travel to Sri Lanka. Corbett will collect blood samples to search for a specific antibody response to the dengue virus, a key step in creating a vaccine for the world's most widespread mosquito-borne disease.
The new technique, developed by UNC researchers, would be cheaper and could allow doctors to visualize tumors without the use of radiation.
UNC School of Medicine's William Valdar and James Crowley lead a quest to discover the genetic underpinnings of drug side effects.
This research could reduce the need to continually monitor patients who respond well to stereotactic radiosurgery.
Wolfgang Bergmeier, PhD, will use the $400,000 award to study the role of blood platelets in inflammation and injury.
Past winners include four scientists who went on to win the Nobel Prize.
Two new studies provide further evidence that schizophrenia arises from the combined effects of many genes. Dr. Patrick Sullivan of UNC is a co-author of one of the studies.
A UNC-led study finds chronic pain to be common among people involved in car accidents. However, most people in the study who reported persistent neck pain were not engaged in litigation six weeks after their accident.
New targeted therapies for pain, Parkinson's disease, and depression carry the promise of greater benefit for patients without serious side effects.
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.
The next chapter in the story of UNC Lineberger Comprehensive Cancer Center begins with a new director, Ned Sharpless, an oncologist with a story to tell.